Stay updated on Risdiplam in SMA Type 2/3: Clinical Trial
Sign up to get notified when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.
Latest updates to the Risdiplam in SMA Type 2/3: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded note that publications are automatically filled from PubMed and may not all pertain to the study. The revision label was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%
- Check27 days agoChange DetectedRemoved an operational government funding notice; study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check42 days agoChange DetectedThe update shows minor changes to the page, such as revised Study Record Dates and small formatting adjustments; there are no edits to core study details, eligibility criteria, arms, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check71 days agoChange DetectedUpdate to version v3.2.0, addition of the Spinal muscular atrophy resource, and a government funding/status notice.SummaryDifference1%
- Check78 days agoChange DetectedPage updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.SummaryDifference0.1%
- Check93 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; this indicates an updated release. Back to Top was removed, a minor UI change.SummaryDifference0.1%
Stay in the know with updates to Risdiplam in SMA Type 2/3: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risdiplam in SMA Type 2/3: Clinical Trial page.